FDA Warning Letter — Novo Nordisk Inc.
The FDA took a Warning Letter action against Novo Nordisk Inc. on September 9, 2025 (Plainsboro, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Novo Nordisk Inc.
- Date
- September 9, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Plainsboro, NJ (United States)